메뉴 건너뛰기




Volumn 6, Issue 2, 2003, Pages 61-73

Economic considerations for health insurance coverage of emerging genetic tests

Author keywords

Economics legislation and jurisprudence; Genetics; Health policy; Insurance coverage

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DECISION MAKING; ECONOMIC ASPECT; EVALUATION; GENETIC PROCEDURES; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH INSURANCE; MOLECULAR GENETICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

EID: 0142156674     PISSN: 14222795     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072998     Document Type: Review
Times cited : (22)

References (68)
  • 2
    • 0142251314 scopus 로고    scopus 로고
    • Toronto Ontario Ministry of Health and Long Term Care, November
    • Ontario Provincial Advisory Committee on New Predictive Genetic Technologies: Genetic Services in Ontario: Mapping the Future. Toronto Ontario Ministry of Health and Long Term Care, November 2001.
    • (2001) Mapping the Future
  • 3
    • 0035849327 scopus 로고    scopus 로고
    • Appraising organised screening progammes for testing for genetic susceptibility to cancer
    • Goel V (for the 'Crossroads 99 Group'): Appraising organised screening progammes for testing for genetic susceptibility to cancer. Br Med J 2001;322:1174-1178.
    • (2001) Br Med J , vol.322 , pp. 1174-1178
    • Goel, V.1
  • 6
    • 0033050583 scopus 로고    scopus 로고
    • Screening blood donors for hereditary hemochromatosis: Decision analysis model comparing genotyping to phenotyping
    • Adams PC, Valberg LS: Screening blood donors for hereditary hemochromatosis: Decision analysis model comparing genotyping to phenotyping. Am J Gastroenterol 1999;94:1593-1600.
    • (1999) Am J Gastroenterol , vol.94 , pp. 1593-1600
    • Adams, P.C.1    Valberg, L.S.2
  • 8
    • 0034674915 scopus 로고    scopus 로고
    • Randomized trial of a specialist genetic assessment service for familial breast cancer
    • Brain K, Gray J, Norman P, France E, Anglim C, Barton G, et al: Randomized trial of a specialist genetic assessment service for familial breast cancer. J Natl Cancer Inst 2000;92:1345-1351.
    • (2000) J Natl Cancer Inst , vol.92 , pp. 1345-1351
    • Brain, K.1    Gray, J.2    Norman, P.3    France, E.4    Anglim, C.5    Barton, G.6
  • 9
    • 0033214004 scopus 로고    scopus 로고
    • Screening for factor V Leiden mutation before prescribing combination oral contraceptives
    • Creinin MD, Lisman R, Strickler RC: Screening for factor V Leiden mutation before prescribing combination oral contraceptives. Fertil Steril 1999;72:646-651.
    • (1999) Fertil Steril , vol.72 , pp. 646-651
    • Creinin, M.D.1    Lisman, R.2    Strickler, R.C.3
  • 10
    • 0031766169 scopus 로고    scopus 로고
    • Genetic and biochemical screening for endocrine disease. III. Costs and logistics
    • Delbridge L, Robinson B: Genetic and biochemical screening for endocrine disease. III. Costs and logistics. World J Surg 1998;22:1212-1217.
    • (1998) World J Surg , vol.22 , pp. 1212-1217
    • Delbridge, L.1    Robinson, B.2
  • 12
    • 0032757171 scopus 로고    scopus 로고
    • Costs and benefits of diagnosing familial breast cancer
    • Heimdal K, Maehle L, Moller P: Costs and benefits of diagnosing familial breast cancer. Dis Markers 1999;15:167-173.
    • (1999) Dis Markers , vol.15 , pp. 167-173
    • Heimdal, K.1    Maehle, L.2    Moller, P.3
  • 13
    • 0036604149 scopus 로고    scopus 로고
    • Will testing alter the management of disease caused by infectious agents? A cost-effectiveness analysis of gene-testing strategies for prevention of rheumatic fever
    • King CH, Fischler DF, Gerkin RD: Will testing alter the management of disease caused by infectious agents? A cost-effectiveness analysis of gene-testing strategies for prevention of rheumatic fever. Clin Infect Dis 2002;34:1491-1499.
    • (2002) Clin Infect Dis , vol.34 , pp. 1491-1499
    • King, C.H.1    Fischler, D.F.2    Gerkin, R.D.3
  • 14
    • 0034942439 scopus 로고    scopus 로고
    • Cost-effectiveness of screening and extended anticoagulation for carriers of both factor V Leiden and prothrombin G20210A
    • Marchetti M, Quaglini S, Barosi G: Cost-effectiveness of screening and extended anticoagulation for carriers of both factor V Leiden and prothrombin G20210A. QJM 2001;94:365-372.
    • (2001) QJM , vol.94 , pp. 365-372
    • Marchetti, M.1    Quaglini, S.2    Barosi, G.3
  • 15
    • 0033026698 scopus 로고    scopus 로고
    • A cost-benefit analysis of genetic screening for susceptibility to occupational toxicants
    • Nicas M, Lomax GP: A cost-benefit analysis of genetic screening for susceptibility to occupational toxicants. J Occup Environ Med 1999;41:535-544.
    • (1999) J Occup Environ Med , vol.41 , pp. 535-544
    • Nicas, M.1    Lomax, G.P.2
  • 16
    • 0032231384 scopus 로고    scopus 로고
    • Prenatal screening for cystic fibrosis carriers: An economic evaluation
    • Rowley PT, Loader S, Kaplan RM: Prenatal screening for cystic fibrosis carriers: An economic evaluation. Am J Hum Genet 1998;63:1160-1174.
    • (1998) Am J Hum Genet , vol.63 , pp. 1160-1174
    • Rowley, P.T.1    Loader, S.2    Kaplan, R.M.3
  • 20
    • 0033157130 scopus 로고    scopus 로고
    • Cost and effectiveness of the California triple marker prenatal screening program
    • Cunningham GC, Tompkinison DG: Cost and effectiveness of the California triple marker prenatal screening program. Genet Med 1999;1:199-206.
    • (1999) Genet Med , vol.1 , pp. 199-206
    • Cunningham, G.C.1    Tompkinison, D.G.2
  • 22
    • 0032965795 scopus 로고    scopus 로고
    • Cost comparison of predictive genetic testing versus conventional clinical screening for familial adenomatous polyposis
    • Bapat B, Noorani H, Cohen D, Berk T, Mitri A, Gallie B, et al.: Cost comparison of predictive genetic testing versus conventional clinical screening for familial adenomatous polyposis. Gut 1999;44:698-703.
    • (1999) Gut , vol.44 , pp. 698-703
    • Bapat, B.1    Noorani, H.2    Cohen, D.3    Berk, T.4    Mitri, A.5    Gallie, B.6
  • 23
    • 0032080634 scopus 로고    scopus 로고
    • A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers
    • Vasen HF, van Ballegooijen M, Buskens E, Kleibeuker JK, Taal BG, Griffioen G, et al: A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers. Cancer 1998;82:1632-1637.
    • (1998) Cancer , vol.82 , pp. 1632-1637
    • Vasen, H.F.1    Van Ballegooijen, M.2    Buskens, E.3    Kleibeuker, J.K.4    Taal, B.G.5    Griffioen, G.6
  • 24
    • 0036117928 scopus 로고    scopus 로고
    • Cost-minimization analysis of genetic testing versus clinical screening of at-risk relatives for familial adenomatous polyposis
    • Chikhaoui Y, Gelinas H, Joseph L, Lance JM: Cost-minimization analysis of genetic testing versus clinical screening of at-risk relatives for familial adenomatous polyposis. Int J Technol Assess Health Care 2002;18:67-80.
    • (2002) Int J Technol Assess Health Care , vol.18 , pp. 67-80
    • Chikhaoui, Y.1    Gelinas, H.2    Joseph, L.3    Lance, J.M.4
  • 27
    • 0035552674 scopus 로고    scopus 로고
    • Screening of newborns for genetic and metabolic disorders: Must health care providers seek explicit parental consent?
    • Wildeman S, Downie J: Screening of newborns for genetic and metabolic disorders: Must health care providers seek explicit parental consent? Health Law J 2001;9:61.
    • (2001) Health Law J , vol.9 , pp. 61
    • Wildeman, S.1    Downie, J.2
  • 28
    • 0032149011 scopus 로고    scopus 로고
    • Genetic discrimination in the work-place
    • Miller PS: Genetic discrimination in the work-place. J Law Med Ethics 1998;26:189-197.
    • (1998) J Law Med Ethics , vol.26 , pp. 189-197
    • Miller, P.S.1
  • 30
    • 0031031739 scopus 로고    scopus 로고
    • Does 'process utility' exist? A case study of willingness to pay for laparoscopic cholecystectomy
    • Donaldson C, Shackley P: Does 'process utility' exist? A case study of willingness to pay for laparoscopic cholecystectomy. Soc Sci Med 1997;44:699-707.
    • (1997) Soc Sci Med , vol.44 , pp. 699-707
    • Donaldson, C.1    Shackley, P.2
  • 31
    • 0021856436 scopus 로고
    • What do patients value? A case study of willingness to pay for ultrasound in normal pregnancy
    • Berwick D, Weinstein M: What do patients value? A case study of willingness to pay for ultrasound in normal pregnancy. Med Care 1985;23:881-893.
    • (1985) Med Care , vol.23 , pp. 881-893
    • Berwick, D.1    Weinstein, M.2
  • 32
    • 0029165307 scopus 로고
    • Health policy approaches to measuring and valuing human life: Conceptual and ethical issues
    • Morrow RH, Bryant JH: Health policy approaches to measuring and valuing human life: Conceptual and ethical issues. Am J Publ Health 1995;85:1356-1360.
    • (1995) Am J Publ Health , vol.85 , pp. 1356-1360
    • Morrow, R.H.1    Bryant, J.H.2
  • 33
    • 0029355702 scopus 로고
    • Why the NHS should abandon the search for the universal outcome measure
    • Brown RB, McCartney S, Bell L: Why the NHS should abandon the search for the universal outcome measure. Health Care Anal 1995;3:191-195.
    • (1995) Health Care Anal , vol.3 , pp. 191-195
    • Brown, R.B.1    McCartney, S.2    Bell, L.3
  • 34
    • 0030055180 scopus 로고    scopus 로고
    • When do the 'dollars' make sense? Toward a conceptual framework for contingent valuation studies in health care
    • O'Brien B, Gafni A: When do the 'dollars' make sense? Toward a conceptual framework for contingent valuation studies in health care. Med Decis Making 1996;16:288-299.
    • (1996) Med Decis Making , vol.16 , pp. 288-299
    • O'Brien, B.1    Gafni, A.2
  • 35
    • 0029399710 scopus 로고
    • Willingness to pay for antenatal carrier screening for cystic fibrosis
    • Donaldson C, Shackley P, Abdalla M, Miedzybrodzka Z: Willingness to pay for antenatal carrier screening for cystic fibrosis. Health Econ 1995;4:439-452.
    • (1995) Health Econ , vol.4 , pp. 439-452
    • Donaldson, C.1    Shackley, P.2    Abdalla, M.3    Miedzybrodzka, Z.4
  • 37
    • 0032814579 scopus 로고    scopus 로고
    • The 'which' hunt: Assembling health technologies for assessment and rationing
    • Giacomini M: The 'which' hunt: Assembling health technologies for assessment and rationing. J Health Polit Policy Law 1999;24:715-758.
    • (1999) J Health Polit Policy Law , vol.24 , pp. 715-758
    • Giacomini, M.1
  • 38
    • 0002636866 scopus 로고
    • The technological imperative in medical practice: The social creation of a 'routine' treatment
    • Lock M, Gordon DR (eds). New York, Kluwer Academic Publishers
    • Koenig BA: The technological imperative in medical practice: The social creation of a 'routine' treatment; in Lock M, Gordon DR (eds): Biomedicine Examined. New York, Kluwer Academic Publishers, 1988, p. 465-496.
    • (1988) Biomedicine Examined , pp. 465-496
    • Koenig, B.A.1
  • 40
    • 0033181470 scopus 로고    scopus 로고
    • Doing the right thing: Genetic risk and responsibility
    • Hallowell N: Doing the right thing: Genetic risk and responsibility. Sociol Health Illness 1999;21:597-621.
    • (1999) Sociol Health Illness , vol.21 , pp. 597-621
    • Hallowell, N.1
  • 41
    • 0033181469 scopus 로고    scopus 로고
    • 'There's this thing in our family': Predictive testing and the construction of risk for Huntington disease
    • Cox SM, McKellin W: 'There's this thing in our family': Predictive testing and the construction of risk for Huntington disease. Sociol Health Illness 1999;21:622-646.
    • (1999) Sociol Health Illness , vol.21 , pp. 622-646
    • Cox, S.M.1    McKellin, W.2
  • 42
    • 21544476206 scopus 로고    scopus 로고
    • Embodying risk, embodying political rationality: Women's accounts of risks for breast cancer
    • Robertson A: Embodying risk, embodying political rationality: Women's accounts of risks for breast cancer. Health, Risk, Society 2000;2:219-235.
    • (2000) Health, Risk, Society , vol.2 , pp. 219-235
    • Robertson, A.1
  • 43
    • 0142220299 scopus 로고    scopus 로고
    • Banishing risk: Continuity and change in the moral management of disease
    • Brandt AM, Rozin P (eds). New York, Routledge
    • Rosenberg C: Banishing risk: Continuity and change in the moral management of disease; in Brandt AM, Rozin P (eds): Morality and Health. New York, Routledge, 1997.
    • (1997) Morality and Health
    • Rosenberg, C.1
  • 44
    • 0032862418 scopus 로고    scopus 로고
    • Knowledge of no return: Getting and giving information about genetic risk
    • Sachs L: Knowledge of no return: Getting and giving information about genetic risk. Acta Oncol 1999;38:735-740.
    • (1999) Acta Oncol , vol.38 , pp. 735-740
    • Sachs, L.1
  • 45
    • 0031051017 scopus 로고    scopus 로고
    • Screening could seriously damage your health
    • Stewart-Brown S, Famer A: Screening could seriously damage your health. Br Med J 1997;314:533.
    • (1997) Br Med J , vol.314 , pp. 533
    • Stewart-Brown, S.1    Famer, A.2
  • 46
    • 85136346361 scopus 로고    scopus 로고
    • Informed choice in cancer screening
    • Welch G: Informed choice in cancer screening. JAMA 2001;285.
    • (2001) JAMA , pp. 285
    • Welch, G.1
  • 47
    • 0038753510 scopus 로고    scopus 로고
    • Private parties, public duties? The shifting role of insurance in the genetics era
    • Thomson A (ed). New York, Kluwer Academic/Plenum Press
    • Lemmens T: Private parties, public duties? The shifting role of insurance in the genetics era; in Thomson A (ed): Genetic Information: Acquisition, Access, and Control. New York, Kluwer Academic/Plenum Press, 1999, pp 31-99.
    • (1999) Genetic Information: Acquisition, Access, and Control , pp. 31-99
    • Lemmens, T.1
  • 48
    • 0003627855 scopus 로고
    • Zoetermeer, Ministry of Welfare, Health and Social Affairs
    • Government Committee on Choices in Health Care: Choices in Health Care. Zoetermeer, Ministry of Welfare, Health and Social Affairs, 1992.
    • (1992) Choices in Health Care
  • 49
    • 0026909689 scopus 로고
    • Equity and solidarity: The context of health care in the Netherlands
    • ten Have H, Keasberry H: Equity and solidarity: The context of health care in the Netherlands. J Med Philos 1992;17(4):463-477.
    • (1992) J Med Philos , vol.17 , Issue.4 , pp. 463-477
    • Ten Have, H.1    Keasberry, H.2
  • 50
    • 0027980512 scopus 로고
    • Epidemiology and the web of causation: Has anyone seen the spider?
    • Krieger N: Epidemiology and the web of causation: Has anyone seen the spider? Soc Sci Med 1994;39:887-903.
    • (1994) Soc Sci Med , vol.39 , pp. 887-903
    • Krieger, N.1
  • 52
    • 0030803565 scopus 로고    scopus 로고
    • Why women say yes to prenatal diagnosis
    • Press N, Brouner CH: Why women say yes to prenatal diagnosis. Soc Sci Med 1997;45:979-989.
    • (1997) Soc Sci Med , vol.45 , pp. 979-989
    • Press, N.1    Brouner, C.H.2
  • 53
    • 0034345130 scopus 로고    scopus 로고
    • (Re)constructing genetic disease: The clinical continuum between cystic fibrosis and male infertility
    • Kerr A: (Re)constructing genetic disease: The clinical continuum between cystic fibrosis and male infertility. Soc Stud Sci 2000;30:847-894.
    • (2000) Soc Stud Sci , vol.30 , pp. 847-894
    • Kerr, A.1
  • 55
    • 0029794708 scopus 로고    scopus 로고
    • Recommendations of the panel on cost-effectiveness in health and medicine
    • Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB: Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 1996;276:1253-1258.
    • (1996) JAMA , vol.276 , pp. 1253-1258
    • Weinstein, M.C.1    Siegel, J.E.2    Gold, M.R.3    Kamlet, M.S.4    Russell, L.B.5
  • 58
    • 0025221029 scopus 로고
    • Philosophical origins of the social rate of discount in cost-benefit analysis
    • Robinson JC: Philosophical origins of the social rate of discount in cost-benefit analysis. Milbank Q 1990;68:245-265.
    • (1990) Milbank Q , vol.68 , pp. 245-265
    • Robinson, J.C.1
  • 59
    • 0034666822 scopus 로고    scopus 로고
    • Health policy and the new genetics
    • Kaufert P: Health policy and the new genetics. Soc Sci Med 2000;51:821-829.
    • (2000) Soc Sci Med , vol.51 , pp. 821-829
    • Kaufert, P.1
  • 62
    • 0029979686 scopus 로고    scopus 로고
    • Cost-effectiveness analysis in a setting of budget constraints - Is it equitable?
    • Ubel PA, DeKay ML, Baron J, Asch DA: Cost-effectiveness analysis in a setting of budget constraints - is it equitable? N Engl J Med 1996;334:1174-1177.
    • (1996) N Engl J Med , vol.334 , pp. 1174-1177
    • Ubel, P.A.1    DeKay, M.L.2    Baron, J.3    Asch, D.A.4
  • 63
    • 0003412671 scopus 로고
    • New York, Cambridge University Press
    • Daniels N: Just Health Care. New York, Cambridge University Press, 1985.
    • (1985) Just Health Care
    • Daniels, N.1
  • 64
    • 0027538777 scopus 로고
    • What does equity in health mean?
    • Pereira J: What does equity in health mean? J Soc Policy 1993;22:19-48.
    • (1993) J Soc Policy , vol.22 , pp. 19-48
    • Pereira, J.1
  • 65
    • 0031471324 scopus 로고    scopus 로고
    • Theories of justice and their implications for priority setting in health care
    • Olsen JA: Theories of justice and their implications for priority setting in health care. J Health Econ 1997;16:625-639.
    • (1997) J Health Econ , vol.16 , pp. 625-639
    • Olsen, J.A.1
  • 67
    • 0011790229 scopus 로고    scopus 로고
    • A tale of two (or more) cities: Geographic transferability of pharmacoeconomic data
    • O'Brien BJ: A tale of two (or more) cities: Geographic transferability of pharmacoeconomic data. Am J Managed Care 1997;3:S33-S40.
    • (1997) Am J Managed Care , vol.3
    • O'Brien, B.J.1
  • 68
    • 0038692884 scopus 로고    scopus 로고
    • Confronting the 'grey zones' of technology assessment: Evaluating genetic testing services for public insurance coverage in Canada
    • Giacomini M, Miller F, Browman G: Confronting the 'grey zones' of technology assessment: Evaluating genetic testing services for public insurance coverage in Canada. Int J Technol Assess Health Care 2003;19:301-316.
    • (2003) Int J Technol Assess Health Care , vol.19 , pp. 301-316
    • Giacomini, M.1    Miller, F.2    Browman, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.